Market Size and Projected Growth
The total estimated size of the U.S. nutraceuticals market reached $142 billion in 2020 according to the Nutrition Business Journal. This represents significant year-over-year growth of 8.4% during the COVID-19 pandemic as consumers took proactive steps to boost immunity and overall wellness. Dietary supplements have seen consistently rising sales over the past decade driven by factors such as aging demographics and growing emphasis on preventive healthcare approaches. The 2020 annual growth rate outpaced recent years, but it was below the industry’s historical average of around 9% growth.
Projections estimate the market will reach $189 billion in the U.S. by 2025, representing a projected compound annual growth rate (CAGR) of 5.8% over the 2020-2025 period as the pandemic boost levels off. Dietary supplements, probiotics and omega-3 products are anticipated to experience above-average growth rates. Emerging areas like nootropics, adaptogens, mushroom-based supplements and CBD products also have strong potential to drive new opportunities. The U.S. Nutraceuticals Market Trends has proven highly resilient through economic cycles, but geopolitical and supply chain issues could potentially temper projections over the next few years.
Emerging Trends Impacting Growth
Several current and expected future trends are impacting players in the U.S. nutraceuticals market both positively and negatively. One megatrend is the broad societal shift toward preventive healthcare and proactive wellness maintenance versus just treatment of illness. The pandemic heightened awareness of immunity and overall well-being. This drives demand but also places added regulatory scrutiny on health claims. Growing environmental, social and governance (ESG) priorities increase consumer preference for natural, clean label, organic and sustainably-sourced ingredients like turmeric, mushrooms and marine oils. However, these traits tend to increase production costs.
Gets More Insights on: U.S. Nutraceuticals Market
